Items where authors include "Shaw, P."

Article

Costello, E. orcid.org/0000-0001-8620-9531, De Vocht, J., Beswick, E. et al. (29 more authors) (2025) Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonization. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. ISSN 2167-8421

McFarlane, R. orcid.org/0000-0001-7380-4219, Opie-Martin, S., Caravaca Puchades, A. et al. (26 more authors) (2025) Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup 1). pp. 41-49. ISSN 2167-8421

McDonough, H., McFarlane, R. orcid.org/0000-0001-7380-4219, Caravaca Puchades, A. et al. (26 more authors) (2025) Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup 1). pp. 20-29. ISSN 2167-8421

Caravaca Puchades, A., McDonough, H.E., Al-Chalabi, A. et al. (26 more authors) (2025) Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 8-19. ISSN 2167-8421

Vasta, R., Ombelet, F., Hobin, F. et al. (26 more authors) (2025) Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 50-60. ISSN 2167-8421

Sennfält, S., Al-Chalabi, A., Caravaca Puchades, A. et al. (26 more authors) (2025) Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 61-72. ISSN 2167-8421

Dewachter, I., Höglinger, G.U., Drucker, D.J. et al. (6 more authors) (2025) A peek into the pipeline: expert views on emerging therapies. Cell Reports Medicine, 6 (4). 102083. ISSN 2666-3791

Pecorari, D., Malmström, H. and Shaw, P. (2024) Reading Speed and Reading Comprehension in an English-Medium Instruction Context. Reading in a Foreign Language, 36 (1). ISSN 1539-0578

Alarcan, H. orcid.org/0009-0002-8788-2773, Bruno, C., Emond, P. et al. (20 more authors) (2024) Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis. Annals of the New York Academy of Sciences, 1536 (1). pp. 82-91. ISSN 0077-8923

Bell, S.M. orcid.org/0000-0002-2781-6478, Wareing, H., Hamshaw, A. et al. (8 more authors) (2023) Deficits in mitochondrial function and glucose metabolism seen in sporadic and familial Alzheimer’s disease derived Astrocytes are ameliorated by increasing hexokinase 1. Alzheimer's & Dementia, 19 (S13). e074618. ISSN 1552-5260

Lombardo, F.L. orcid.org/0000-0001-6183-0735, Spila Alegiani, S., Mayer, F. et al. (93 more authors) (2023) A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Trials, 24 (1). 792. ISSN 1468-6708

Castelli, L.M., Lin, Y.-H., Sanchez-Martinez, A. et al. (19 more authors) (2023) A cell-penetrant peptide blocking C9ORF72-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins. Science Translational Medicine, 15 (685). ISSN 1946-6234

Horne, A., Brown, S., Butterworth, K. et al. (26 more authors) (2022) EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 17 (9). s267-s268. ISSN 1556-0864

Shaw, P. orcid.org/0000-0002-8925-2567, Miller, T., Cudkowicz, M. et al. (7 more authors) (2022) Tofersen in adults with SOD1-ALS: phase 3 VALOR trial and open-label extension results. Journal of Neurology, Neurosurgery & Psychiatry, 93 (9). e2. ISSN 0022-3050

White, S., Zarotti, N., Beever, D. orcid.org/0000-0001-9063-3677 et al. (22 more authors) (2021) The nutritional management of people living with Amyotrophic Lateral Sclerosis (ALS): A national survey of dietitians. Journal of Human Nutrition and Dietetics, 34 (6). pp. 1064-1071. ISSN 0952-3871

Fennell, D.A., Ewings, S., Ottensmeier, C. et al. (36 more authors) (2021) Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. The Lancet Oncology, 22 (11). pp. 1530-1540. ISSN 1470-2045

Sassani, M., Alix, J., McDermott, C. et al. (6 more authors) (2020) Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis. Brain, 143 (12). pp. 3603-3618. ISSN 0006-8950

Zarotti, N. orcid.org/0000-0002-8129-6151, Coates, E., McGeachan, A. et al. (22 more authors) (2019) Health care professionals’ views on psychological factors affecting nutritional behaviour in people with motor neuron disease : a thematic analysis. British Journal of Health Psychology, 24 (4). pp. 953-969. ISSN 1359-107X

Al-Chalabi, A., Shaw, P. orcid.org/0000-0002-8925-2567, Leigh, P.N. et al. (6 more authors) (2019) Oral levosimendan in amyotrophic lateral sclerosis : a phase II multicentre, randomised, double-blind, placebo-controlled trial. Journal of Neurology, Neurosurgery & Psychiatry, 90 (10). pp. 1165-1170. ISSN 0022-3050

Weeks, K., Gould, R., McDermott, C. et al. (13 more authors) (2019) Needs and preferences for psychological interventions of people with motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20 (7-8). pp. 521-531. ISSN 2167-9223

Allen, S., Hall, B., Castelli, L. et al. (19 more authors) (2019) Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain, 142 (3). pp. 586-605. ISSN 0006-8950

Ferraiuolo, L. orcid.org/0000-0001-9118-5714 and Shaw, P. orcid.org/0000-0002-8925-2567 (2018) Lost in translation: microRNAs mediate pathological cross-talk between motor neurons and astrocytes. Brain, 141 (9). pp. 2534-2536. ISSN 0006-8950

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Jenkins, T., Alix, J. orcid.org/0000-0001-8391-9749, David, C. et al. (10 more authors) (2018) Imaging muscle as a potential biomarker of denervation in motor neuron disease. Journal of Neurology, Neurosurgery and Psychiatry, 89. pp. 248-255. ISSN 0022-3050

Waller, R. orcid.org/0000-0001-5815-8829, Wyles, M., Heath, P.R. et al. (4 more authors) (2018) Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Frontiers in Neuroscience, 11. 731. ISSN 1662-4548

Al-Chalabi, A. orcid.org/0000-0002-4924-7712, Andersen, P.M., Chandran, S. et al. (38 more authors) (2017) July 2017 ENCALS statement on edaravone. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18 (7-8). pp. 471-474. ISSN 2167-8421

Dolzhenko, E., van Vugt, J.J.F.A., Shaw, R.J. et al. (42 more authors) (2017) Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Research , 27. pp. 1895-1903. ISSN 1088-9051

Waller, R. orcid.org/0000-0001-5815-8829, Goodall, E.F., Milo, M. et al. (8 more authors) (2017) Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Neurobiology of Aging, 55. pp. 123-131. ISSN 0197-4580

Webster, C., Smith, E., Shaw, P. et al. (1 more author) (2017) Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities? Frontiers in Molecular Neuroscience, 10. 123. ISSN 1662-5099

Oeckl, P., Jardel, C., Salachas, F. et al. (32 more authors) (2016) Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. pp. 1-10. ISSN 2167-8421

Hobson, E.V. orcid.org/0000-0002-8497-2338, Baird, W., Cooper, C. et al. (3 more authors) (2016) Using technology to improve access to specialist care in amyotrophic lateral sclerosis: A systematic review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17 (5-6). pp. 313-324. ISSN 2167-8421

Tian, X., Nyberg, S., Sharp, P.S. et al. (8 more authors) (2015) LRP-1-mediated intracellular antibody delivery to the Central Nervous System. Scientific Reports, 5. 11990. ISSN 2045-2322

Agosta, F., Al-Chalabi, A., Filippi, M. et al. (9 more authors) (2014) The El Escorial criteria: Strengths and weaknesses. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16 (1-2). pp. 1-7. ISSN 2167-8421

Law, J., Shaw, P., Earland, K. et al. (2 more authors) (2014) A psychology based approach for longitudinal development in cognitive robotics. Frontiers in Neurorobotics, 8. ARTN 1. ISSN 1662-5218

Earland, K., Lee, M., Shaw, P. et al. (1 more author) (2014) Overlapping Structures in Sensory-Motor Mappings. PLoS ONE, 9 (1). e84240. ISSN 1932-6203

Conference or Workshop Item

Horne, A., Ali, A., Brown, S. et al. (28 more authors) (2022) 153 CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). In: 20th Annual British Thoracic Oncology Group Conference 2022, 27-28 Jan 2022, Virtual.

Proceedings Paper

Walls, G., Horne, A., Harrow, S. et al. (17 more authors) (2025) 3513: ATM inhibition with AZD1390 and conventional radiotherapy in non-small cell lung cancer: interim report from the CONCORDE phase Ib trial (NCT04550104). In: Radiotherapy and Oncology. ESTRO 2025, 02-06 May 2025, Vienna, Austria. , s1395-s1397.

Horne, A., Walls, G., Brown, S. et al. (17 more authors) (2025) An update on the CONCORDE study: a phase Ib platform study of DNA damage repair inhibitors (DDRIs) in combination with conventional radiotherapy in NSCLC. In: Journal of Thoracic Oncology. European Lung Cancer Congress 2025, 26-29 Mar 2025, Paris, France. Elsevier BV , S150.

Walls, G., Horne, A., Franks, K. et al. (23 more authors) (2025) 255 An update on the CONCORDE study: a phase Ib platform study of DNA damage repair inhibitors (DDRis) in combination with conventional radiotherapy in NSCLC. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108364.

Greystoke, A., Oughton, J.B., Brown, S.R. et al. (16 more authors) (2024) Olaparib, AZD1390, ceralasertib, saruparib and consolidation durvalumab (CONCORDE) phase Ib platform study of novel DNA damage response inhibitor (DDRi) agents in combination with radiotherapy in non-small cell lung cancer (NSCLC). In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. ASCO Publications .

Horne, A., Brown, S., Gilbert, A. et al. (16 more authors) (2024) Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm. In: Radiotherapy and Oncology. ESTRO 2024, 03-07 May 2024, Glasgow, UK. , S1652-S1655.

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier BV , S296-S297.

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier , S296-S297.

Chapman, L. orcid.org/0000-0001-6174-9435, Shepheard, S., Verber, N. et al. (4 more authors) (2022) 171 Urinary P75: a novel biomarker for motor neuron disease? In: Journal of Neurology, Neurosurgery & Psychiatry. ABN Annual Meeting 2022, 17-20 May 2022, Harrogate, UK. BMJ , e2.130-e2.130.

Franklin, J., Cooper-Knock, J. orcid.org/0000-0002-0873-8689, Baheerathan, A. et al. (6 more authors) (2022) Concurrent sodium channel myotonia and amyotrophic lateral sclerosis supports shared pathogenesis. In: Journal of Neurology, Neurosurgery & Psychiatry. ABN Annual Meeting 2020, 07 Sep - 12 Nov 2020, Virtual, online. BMJ , A13-A13.

Price, K., Mellor, J., Mcnamara, M. et al. (4 more authors) (2022) Large single-centre cohort of HSP patients in UK: advantages of deep pheno- typing and longitudinal follow-up. In: Journal of Neurology, Neurosurgery & Psychiatry. ABN Annual Meeting 2020, 07 Sep - 12 Nov 2020, Virtual, online. BMJ , A10-A10.

Sassani, M., Alix, J. orcid.org/0000-0001-8391-9749, Mcdermott, C. et al. (7 more authors) (2021) Brain energy metabolism in ALS : a phosphorus-31 magnetic resonance spectroscopy study. In: Journal of the Neurological Sciences. World Congress of Neurology (WCN 2021), 03-07 Oct 2021, Rome, Italy. Elsevier BV , p. 119412.

Shaw, P. orcid.org/0000-0002-8925-2567 (2021) New therapies for MND. In: Journal of the Neurological Sciences. World Congress of Neurology (WCN 2021), 03-07 Oct 2021, Rome, Italy. Elsevier BV .

Bell, S., De Marco, M., Barnes, K. et al. (5 more authors) (2020) Do deficits in mitochondrial spare respiratory capacity contribute to neuropsychological changes seen in Alzheimer's disease? In: Neurology. UNSPECIFIED. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology .

Bell, S. orcid.org/0000-0002-2781-6478, De Marco, M., Barnes, K. et al. (5 more authors) (2020) Do deficits in mitochondrial spare respiratory capacity contribute to neuropsychological changes seen in Alzheimer’s disease? (798). In: Merino, J.G., (ed.) Neurology. 2020 AAN Annual Meeting, 25 Apr - 01 May 2020, Toronto, Canada (cancelled Due to COVID-19). Ovid Technologies (Wolters Kluwer Health) .

Jenkins, T., Alix, J. orcid.org/0000-0001-8391-9749, Rao, G. et al. (8 more authors) (2017) Imaging denervation in motor neuron disease for future clinical trials: a longitudinal cohort study. In: Journal of the Neurological Sciences. World Congress of Neurology (WCN 2017), 16-21 Sep 2017, Kyoto, Japan. https://doi.org/10.1016/j.jns.2017.08.328, 381s . Elsevier , p. 102.

Hewamadduma, C.A., Omalley, R., Robinson, M. et al. (7 more authors) (2017) Mutations in SPG7 as an important cause of spastic-ataxia in a large british cohort: Hybrid phenotype helps direct screening. In: Journal of the Neurological Sciences. World Congress of Neurology (WCN 2017), 16-21 Sep 2017, Kyoto, Japan. Elsevier , pp. 304-305.

Rafiq, M., Proctor, A., McDermott, C. et al. (1 more author) (2015) Screening for respiratory failure in ALS using clinical questioning, respiratory function tests and transcutaneous carbon dioxide: which is the better tool? In: Journal of Neurology, Neurosurgery and Psychiatry. 2015 ABN Annual Meeting, 10 September 2015, Institute of Education, London. .

Rafiq, M., Lee, E., Bradburn, M. et al. (2 more authors) (2015) Elevated creatine kinase is associated with a better prognosis in patients with amyotrophic lateral sclerosis. In: Neurology. AAN 67th Annual Meeting, 18-24 Apr 2015, Washington D.C.. American Academy of Neurology , p. 741.

Other

Shaw, P. orcid.org/0000-0002-8925-2567 (2022) Oxidative stress in amyotrophic lateral sclerosis (ALS) 1. The Biomedical & Life Sciences Collection, Henry Stewart Talks.

Shaw, P. orcid.org/0000-0002-8925-2567 (2022) Oxidative stress in amyotrophic lateral sclerosis (ALS) 2. Biomedical & Life Sciences Collection, Henry Stewart Talks.

Shaw, P. orcid.org/0000-0002-8925-2567 (2022) SOD1-related ALS: what has it told us about motor neuron degeneration? - part 1. The Biomedical & Life Sciences Collection, Henry Stewart Talks.

Shaw, P. orcid.org/0000-0002-8925-2567 (2022) SOD1-related ALS: what has it told us about motor neuron degeneration? - part 2. The Biomedical & Life Sciences Collection, Henry Stewart Talks.